Publication

Bioassays guided isolation of berberine from Berberis lycium and its neuroprotective role in aluminium chloride induced rat model of Alzheimer’s disease combined with insilico molecular docking

H Ismail , D Khalid , D Waseem , MU Ijaz , E Dilshad , IU Haq , MZ Bhatti , S Anwaar , M Ahmed , S Saleem

PLoS One, 2023 - VOLUME 18, ISSUE 11 , p e0286349
DOI:   10.1371/journal.pone.0286349
PSIID: 188650195


Notices

External Comments, Questions and/or Concerns from:

PubPeer Comment

Dysdera Arabisenen

PubPeer , 2023 - VOLUME 2023, ISSUE 11
  External CQC
0 0
Abstract

OBJECTIVE: Berberis lycium is an indigenous plant of Pakistan that is known for its medicinal properties. In the current study, we investigated the anti-Alzheimer's effect of berberine isolated from Berberis lycium.

METHODS: Root extract of B. lycium was subjected to acetylcholinesterase inhibition assay and column chromatography for bioassays guided isolation of a compound. The neuroprotective and memory improving effects of isolated compound were evaluated by aluminium chloride induced Alzheimer's disease rat model, elevated plus maze (EPM) and Morris water maze (MWM) tests., Levels of dopamine and serotonin in rats brains were determined using HPLC. Moreover, western blot and docking were performed to determine interaction between berberine and β-secretase.

RESULTS: During fractionation, ethyl acetate and methanol (3:7) fraction was collected from solvent mixture of ethyl acetate and methanol. This fraction showed the highest anti-acetylcholinesterase activity and was alkaloid positive. The results of TLC and HPLC analysis indicated the presence of the isolated compound as berberine. Additionally, the confirmation of isolated compound as berberine was carried out using FTIR and NMR analysis. In vivo EPM and MWM tests showed improved memory patterns after berberine treatment in Alzheimer's disease model. The levels of dopamine, serotonin and activity of antioxidant enzymes were significantly (p<0.05) enhanced in brain tissue homogenates of berberine treated group. This was supported by decreased expression of β-secretase in berberine treated rat brain homogenates and good binding affinity of berberine with β-secretase in docking studies. Binding energies for interaction of β-secretase with berberine and drug Rivastigmine is -7.0 kcal/mol and -5.8 kcal/mol respectively representing the strong interactions. The results of docked complex of secretase with berberine and Rivastigmine was carried out using Gromacs which showed significant stability of complex in terms of RMSD and radius of gyration. Overall, the study presents berberine as a potential drug against Alzheimer's disease by providing evidence of its effects in improving memory, neurotransmitter levels and reducing β-secretase expression in the Alzheimer's disease model.

Copyright: © 2023 Ismail et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Go to Website

References
55 RESULTS in 10 msec
2022-02-00

A patent review of berberine and its derivatives with various pharmacological activities (2016-2020).

Y Kong , L Li , LG Zhao , ... , DD Li

Expert Opinion on Therapeutic Patents , 2022 - VOLUME 32, ISSUE 2 , pp 211-223.

10.1080/13543776.2021.1974001

  Review
7 0

2023-05-06

PubPeer Comment

Mycosphaerella Arachidis

PubPeer
2023 - VOLUME 2023, ISSUE 5

  Website - Forum Post External CQC
0 0
2019-01-00

Pharmacological effects of berberine on mood disorders.

J Fan , K Zhang , Y Jin , ... , R Cui

Journal of Cellular and Molecular Medicine , 2019 - VOLUME 23, ISSUE 1 , pp 21-28.

10.1111/jcmm.13930

  Review
27 96

 

2023 - VOLUME 18, ISSUE 11
1576 RESULTS in 101 msec
2023-11-30

Elevated expression of TUBA1C in breast cancer predicts poor prognosis

Y Zhao , W Wang , J Li , ... , G Shen

PLoS One , 2023 - VOLUME 18, ISSUE 11 , p e0263710.

10.1371/journal.pone.0263710

  0 19

2023-11-08

Psychological morbidities among Nepalese migrant workers to Gulf and Malaysia

A Sharma , R Adhikari , E Parajuli , ... , B Adhikari

PLoS One , 2023 - VOLUME 18, ISSUE 11 , p e0267784.

10.1371/journal.pone.0267784

  0 18

2023-11-27

Deep learning for the prediction of clinical outcomes in internet-delivered CBT for depression and anxiety

N Prasad , I Chien , T Regan , ... , A Thieme

PLoS One , 2023 - VOLUME 18, ISSUE 11 , p e0272685.

10.1371/journal.pone.0272685

  0 33

2023-11-29

Mechanical analysis of eight-legged temporary support structure under wave forces

W Wang , YZ Yuan

PLoS One , 2023 - VOLUME 18, ISSUE 11 , p e0277353.

10.1371/journal.pone.0277353

  0 1

2023-11-28

Quantifying gender bias towards politicians in cross-lingual language models

K Stańczak , S Ray Choudhury , T Pimentel , ... , I Augenstein

PLoS One , 2023 - VOLUME 18, ISSUE 11 , p e0277640.

10.1371/journal.pone.0277640

  0 1

 

Cited By
No citations of this publication are currently indexed.
Citation Network
78776 RESULTS in 12 msec
2024-03-00

E674Q (Shanghai APP mutant), a novel amyloid precursor protein mutation, in familial late-onset Alzheimer's disease

Y Zhang , X Xie , B Chen , ... , G Wang

Genes and Diseases , 2024 - VOLUME 11, ISSUE 2 , pp 1022-1034.

10.1016/j.gendis.2023.02.051

  0 33

2024-00-00

Molecular Dynamics and Other HPC Simulations for Drug Discovery.

M Kotev , C Diaz Gonzalez

Methods in Molecular Biology , 2024 - VOLUME 2716 , pp 265-291.

10.1007/978-1-0716-3449-3_12

  0 116

2024-00-00

Automated Virtual Screening.

VJ Sykora

Methods in Molecular Biology , 2024 - VOLUME 2716 , pp 137-152.

10.1007/978-1-0716-3449-3_6

  0 29

2024-00-00

Recent Deep Learning Applications to Structure-Based Drug Design.

J Verburgt , A Jain , D Kihara

Methods in Molecular Biology , 2024 - VOLUME 2714 , pp 215-234.

10.1007/978-1-0716-3441-7_13

  Review
0 46

2024-00-00

Molecular Dynamics as a Tool for Virtual Ligand Screening.

G Menchon , L Maveyraud , G Czaplicki

Methods in Molecular Biology , 2024 - VOLUME 2714 , pp 33-83.

10.1007/978-1-0716-3441-7_3

  0 123

2024-00-00

Antiviral Drug Target Identification and Ligand Discovery.

H Patel , D Sengupta

Methods in Molecular Biology , 2024 - VOLUME 2714 , pp 85-99.

10.1007/978-1-0716-3441-7_4

  Review
0 19

2024-00-00

Protein-Ligand Blind Docking Using CB-Dock2.

Y Liu , Y Cao

Methods in Molecular Biology , 2024 - VOLUME 2714 , pp 113-125.

10.1007/978-1-0716-3441-7_6

  0 30